(Total Views: 69)
Posted On: 10/07/2020 1:45:48 PM
Post# of 85584

$SRNE News Article - Scilex Holding Company, a Subsidiary of Sorrento Therapeutics, Announces Continuous Sales Growth in ZTlido and Expects to Complete Enrollment on its SP-102 (SEMDEXA(TM)) Phase 3 Pivotal Trial Program in 2020 https://marketwirenews.com/news-releases/scil...27124.html


My Twitter: WhyteStocks